Delivery Order SPE2DB22D3016-SPE2DB24FANN9
Award Date
2/28/24
Potential Completion Date
2/29/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,165,480 units of ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $22,056.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with a completion date of October 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of 4,567,372,778 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,665.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,560,801,374 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $9,146.70 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2023, with a completion date of May 3, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of 4,565,255,906 units of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $15,177.45 contract is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,567,227,090 units of 4 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,294.40 firm-fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 11, 2025, with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,643,171 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $2,239.95 contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $1,222.69 for the supply of 4,564,095,638 units of Ondansetron HCL 4 MG tablets. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation, is the prime contractor. This delivery order is part...
This federal contract award is for the delivery of 4,565,471,054 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $25,066.79, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...